🇺🇸 FDA
Patent

US 11504389

Tau modulators and methods and compositions for delivery thereof

granted A61KA61K31/7105A61K38/1709

Quick answer

US patent 11504389 (Tau modulators and methods and compositions for delivery thereof) held by Sangamo Therapeutics, Inc. expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K31/7105, A61K38/1709, A61P, A61P25/28